Traders Buy Large Volume of Call Options on Teladoc Health (NYSE:TDOC)

Teladoc Health, Inc. (NYSE:TDOC) was the recipient of unusually large options trading on Wednesday. Stock investors acquired 55,189 call options on the company. This represents an increase of 138% compared to the typical volume of 23,145 call options.

Teladoc Health Stock Up 8.7%

Shares of TDOC stock opened at $9.10 on Thursday. The firm has a market capitalization of $1.61 billion, a PE ratio of -7.65 and a beta of 1.90. Teladoc Health has a fifty-two week low of $6.35 and a fifty-two week high of $15.21. The stock’s 50-day simple moving average is $7.72 and its 200-day simple moving average is $7.61. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.58 and a current ratio of 2.67.

Teladoc Health (NYSE:TDOC) last posted its earnings results on Tuesday, July 29th. The health services provider reported ($0.19) EPS for the quarter, topping the consensus estimate of ($0.27) by $0.08. The firm had revenue of $631.90 million for the quarter, compared to analyst estimates of $621.91 million. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%.Teladoc Health’s revenue for the quarter was down 1.6% compared to the same quarter last year. During the same period last year, the company earned ($0.38) earnings per share. Teladoc Health has set its Q3 2025 guidance at -0.350–0.200 EPS. FY 2025 guidance at -1.350–1.000 EPS. Equities analysts expect that Teladoc Health will post -1.16 earnings per share for the current year.

Wall Street Analyst Weigh In

TDOC has been the subject of a number of analyst reports. Weiss Ratings restated a “sell (d-)” rating on shares of Teladoc Health in a research note on Wednesday. Evercore ISI increased their price target on Teladoc Health from $8.00 to $9.00 and gave the company an “in-line” rating in a research note on Wednesday. Finally, Mizuho began coverage on Teladoc Health in a research note on Friday, July 25th. They issued a “neutral” rating and a $10.00 price target for the company. Six analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $9.86.

Institutional Trading of Teladoc Health

Several institutional investors have recently bought and sold shares of TDOC. Nuveen LLC acquired a new stake in Teladoc Health in the first quarter valued at approximately $11,789,000. Vanguard Group Inc. grew its holdings in Teladoc Health by 7.0% in the first quarter. Vanguard Group Inc. now owns 19,752,338 shares of the health services provider’s stock valued at $157,229,000 after purchasing an additional 1,289,183 shares during the period. Bridgeway Capital Management LLC acquired a new stake in Teladoc Health in the second quarter valued at approximately $8,729,000. Trexquant Investment LP grew its holdings in Teladoc Health by 198.9% in the first quarter. Trexquant Investment LP now owns 907,859 shares of the health services provider’s stock valued at $7,227,000 after purchasing an additional 604,116 shares during the period. Finally, Empowered Funds LLC acquired a new stake in Teladoc Health in the second quarter valued at approximately $5,040,000. 76.82% of the stock is owned by institutional investors and hedge funds.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.